Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127386161 | 12738616 | 1 | I | 20160407 | 0 | 20160912 | 20160912 | DIR | US-FDA-350401 | FDA-CTU | 31.00 | YR | M | N | 66.15000 | KG | 20160912 | N | PH | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127386161 | 12738616 | 1 | PS | TRIUMEQ | ABACAVIR SULFATEDOLUTEGRAVIR SODIUMLAMIVUDINE | 1 | Oral | N | D | 0 | 1 | DF | QD | ||||||
127386161 | 12738616 | 2 | SS | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | N | D | 0 | 1 | DF | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127386161 | 12738616 | 1 | Acquired immunodeficiency syndrome |
127386161 | 12738616 | 2 | Antifungal prophylaxis |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127386161 | 12738616 | Nausea | |
127386161 | 12738616 | Paraesthesia | |
127386161 | 12738616 | Rash | |
127386161 | 12738616 | Tachycardia | |
127386161 | 12738616 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
Event ID | CASEID | RPSR COD |
---|---|---|
127386161 | 12738616 | HP |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127386161 | 12738616 | 1 | 20160407 | 20160407 | 0 | |
127386161 | 12738616 | 2 | 20160407 | 20160407 | 0 |